Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 494

• Price / Volume Information    Yesterday's Closing Price: $3.19 Daily Weekly Monthly 20 Day Moving Average: 138,559 shares Shares Outstanding: 41.64 (millions) Market Capitalization: $132.82 (millions) Beta: 1.71 52 Week High: $8.48 52 Week Low: $3.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.60% -19.03% 12 Week -14.93% -20.81% Year To Date -54.75% -49.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 info@harvardbioscience.com http://www.harvardbioscience.com

• General Corporate Information    Officers James Green - Chief Executive Officer and Director Michael A. Rossi - Chief Financial Officer Katherine A. Eade - Director Alan Edrick - Director Thomas W. Loewald - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (MTD) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/22 Next Expected EPS Date: 11/02/22 Share - Related Items Shares Outstanding: 41.64 Most Recent Split Date: (:1) Beta: 1.71 Market Capitalization: $132.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/02/22

• Fundamental Ratios P/E Current FY Estimate: 63.80 Trailing 12 Months: 22.79 PEG Ratio: - Price Ratios Price/Book: 1.71 Price/Cash Flow: 8.31 Price / Sales: 1.10 EPS Growth vs. Year Ago Period: -50.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 0.04% vs. Previous Quarter: 1.49% ROE 06/30/22 - 7.74 03/31/22 - 9.06 12/31/21 - 9.78 ROA 06/30/22 - 3.86 03/31/22 - 4.55 12/31/21 - 4.97 Current Ratio 06/30/22 - 2.42 03/31/22 - 2.18 12/31/21 - 2.43 Quick Ratio 06/30/22 - 1.16 03/31/22 - 1.13 12/31/21 - 1.34 Operating Margin 06/30/22 - 5.03 03/31/22 - 5.92 12/31/21 - 6.50 Net Margin 06/30/22 - -3.03 03/31/22 - -5.38 12/31/21 - -0.24 Pre-Tax Margin 06/30/22 - -2.01 03/31/22 - -5.36 12/31/21 - -0.12 Book Value 06/30/22 - 1.86 03/31/22 - 1.85 12/31/21 - 2.04 Inventory Turnover 06/30/22 - 1.86 03/31/22 - 1.96 12/31/21 - 2.03 Debt-to-Equity 06/30/22 - 0.59 03/31/22 - 0.61 12/31/21 - 0.54 Debt-to-Capital 06/30/22 - 37.13 03/31/22 - 37.71 12/31/21 - 35.09

Powered by Zacks Investment Research ©